PHASEBIO
Live / Registered — Registered (as of 25 Apr 2023)
What this means for you
Registered since 25 Apr 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88107576
- Registration number
- 7037266
- Mark type
- Stylized text
- Filed
- 06 Sept 2018
- Published for opposition
- 06 Aug 2019
- Registered
- 25 Apr 2023
- Attorney of record
- Judd D. Lauter
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for treating heart disease, heart conditions, hypertension, pulmonary hypertension, and other disorders of the cardiopulmonary system; pharmaceutical preparations consisting of reversal agents for counteracting the effects of platelet aggregation inhibitors
Owner
- PhaseBio Pharmaceuticals, Inc., Malvern, PA, US
- PhaseBio Pharmaceuticals, Inc., Malvern, PA, US
- PhaseBio Pharmaceuticals, Inc., Malvern, PA, US
Prosecution history
- 25 Apr 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 25 Apr 2023 — REGISTERED-PRINCIPAL REGISTER
- 23 Mar 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 22 Mar 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 16 Mar 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 15 Mar 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 15 Mar 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 24 Oct 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 24 Oct 2022 — NON-FINAL ACTION E-MAILED
- 24 Oct 2022 — SU - NON-FINAL ACTION - WRITTEN
- 02 Oct 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 30 Sept 2022 — USE AMENDMENT FILED
- 30 Sept 2022 — TEAS STATEMENT OF USE RECEIVED
- 24 Feb 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Feb 2022 — SOU EXTENSION 5 GRANTED